BioCardia, Inc. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
BioCardia, Inc. (BCDA) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $271.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-11-09.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2022-11-09
- BioCardia, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-06-30 was $271.00K, a 26.64% increase year-over-year.
- BioCardia, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2021-06-30 was $214.00K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month |
|---|---|
| 2022-06-30 | $271.00K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $214.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |